{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:45:57Z","timestamp":1773481557034,"version":"3.50.1"},"reference-count":22,"publisher":"FapUNIFESP (SciELO)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cad. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:p>O objetivo deste estudo foi estimar a preval\u00eancia de intera\u00e7\u00f5es medicamentosas potenciais entre anti-hipertensivos e outros f\u00e1rmacos. Foi realizado um inqu\u00e9rito domiciliar com pessoas de 60 anos ou mais de idade, residentes no Rio de Janeiro, Brasil. Foram identificadas as intera\u00e7\u00f5es medicamentosas potenciais entre os anti- hipertensivos com evid\u00eancia estabelecida, prov\u00e1vel ou suspeita e com gravidade moderada ou elevada. Foram entrevistados 577 idosos (m\u00e9dia de idade = 72 anos), 45,2% dos quais em uso de anti-hipertensivos, sendo 31,0% deles sujeitos a intera\u00e7\u00f5es medicamentosas potenciais. A maioria das intera\u00e7\u00f5es foi moderadamente grave. Comparados aos demais, os sujeitos \u00e0s intera\u00e7\u00f5es medicamentosas potenciais t\u00eam chance acima de 4 vezes de usar 5 ou mais medicamentos e acima de duas vezes de ter sido hospitalizado no ano anterior. Entre os pares de intera\u00e7\u00f5es mais frequentes, 75% produzem redu\u00e7\u00e3o do efeito hipotensivo (65\/87), o que pode resultar em baixa efetividade no controle da press\u00e3o arterial, prescri\u00e7\u00e3o de mais medicamentos e risco de outros efeitos adversos e de intera\u00e7\u00f5es.<\/jats:p>","DOI":"10.1590\/0102-311x00126213","type":"journal-article","created":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T17:39:14Z","timestamp":1412789954000},"page":"1947-1956","source":"Crossref","is-referenced-by-count":16,"title":["Intera\u00e7\u00f5es medicamentosas potenciais entre idosos em uso dos anti-hipertensivos da Rela\u00e7\u00e3o Nacional de Medicamentos Essenciais do Minist\u00e9rio da Sa\u00fade do Brasil"],"prefix":"10.1590","volume":"30","author":[{"given":"Pablo","family":"Mibielli","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suely","family":"Rozenfeld","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guacira Corr\u00eaa de","family":"Matos","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio de Janeiro, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco de Assis","family":"Acurcio","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(07)61092-7","article-title":"The challenge of managing drug interactions in elderly people","volume":"370","author":"Mallet L","year":"2007","journal-title":"Lancet"},{"key":"ref2","first-page":"35","article-title":"Hipertens\u00e3o arterial no Brasil: estimativa de preval\u00eancia a partir de estudos de base populacional","volume":"15","author":"Passos VMA","year":"2006","journal-title":"Epidemiol Serv Sa\u00fade"},{"key":"ref3","first-page":"7","article-title":"VI diretrizes brasileiras de hipertens\u00e3o","volume":"17","year":"2010","journal-title":"Rev Bras Hipertens"},{"key":"ref4","series-title":"Rela\u00e7\u00e3o Nacional de Medicamentos Essenciais: RENAME","year":"2010","edition":"7"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/S0102-311X2006000100010","article-title":"Utiliza\u00e7\u00e3o de medicamentos por aposentados brasileiros. 1 \u2013 Metodologia e resultados de cobertura de inqu\u00e9rito multic\u00eantrico","volume":"22","author":"Acurcio FA","year":"2006","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"ref6","series-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics. International edition","first-page":"43","volume-title":"Principles of therapeutics","author":"Nies AS","year":"1996"},{"key":"ref7","series-title":"Drug interaction facts","author":"Tatro DS","year":"2011"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2165\/11538460-000000000-00000","article-title":"Risk of potential drug-drug interactions among Brazilian elderly","volume":"27","author":"Secoli SR","year":"2010","journal-title":"Drugs Aging"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00041552-200109000-00012","article-title":"Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?","volume":"10","author":"Cleland JG","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-7-147","article-title":"Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City","volume":"7","author":"Doubova SV","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11096-010-9442-5","article-title":"The incidence of potential drug-drug interactions in elderly patients with arterial hypertension","volume":"32","author":"Bacic-Vrca V","year":"2010","journal-title":"Pharm World Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0895-7061(02)03026-1","article-title":"The extent of potential antihypertensive drug interactions in a Medicaid population","volume":"15","author":"Carter BL","year":"2002","journal-title":"Am J Hypertens"},{"key":"ref13","first-page":"1867","article-title":"Gender differences, polypharmacy, and potential pharmacological interactions in the elderly","volume":"66","author":"Venturini CD","year":"2011","journal-title":"Clinics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00228-007-0394-1","article-title":"Identification of severe potential drug-drug interactions using an Italian general-practitioner database","volume":"64","author":"Magro L","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2125.2006.02809.x","article-title":"Comparative assessment of four drug interaction compendia","volume":"63","author":"Vitry AI","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00002512-200825040-00007","article-title":"Drug-drug interactions in a geriatric outpatient cohort","volume":"25","author":"Tulner LR","year":"2008","journal-title":"Drugs Aging"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18433\/J35C7Z","article-title":"Drug-drug interactions associated with length of stay and cost of hospitalization","volume":"12","author":"Moura C","year":"2009","journal-title":"J Pharm Pharmaceut Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.18553\/jmcp.2011.17.s8.1","article-title":"Updates on the treatment of essential hypertension: a summary of AHRQ\u2019s comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors","volume":"17","author":"Powers B","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ageing\/afn197","article-title":"STOPP (Screening Tool of Older Persons\u2019 potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers\u2019 criteria","volume":"37","author":"Gallagher P","year":"2008","journal-title":"Age Ageing"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2318-11-79","article-title":"Inappropriate medication use among the elderly:a systematic review of administrative databases","volume":"11","author":"Guaraldo L","year":"2011","journal-title":"BMC Geriatr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0735-1097(92)90449-W","article-title":"Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure","volume":"20","author":"Hall D","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"ref22","series-title":"SUS amplia acesso ao tratamento da hipertens\u00e3o arterial","year":"2014"}],"container-title":["Cadernos de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/csp\/v30n9\/0102-311X-csp-30-9-1947.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T13:55:24Z","timestamp":1650376524000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-311X2014000901947&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0102-311X2014000901947"],"URL":"https:\/\/doi.org\/10.1590\/0102-311x00126213","relation":{},"ISSN":["0102-311X"],"issn-type":[{"value":"0102-311X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}